Found 57 structures.
Displayed structures from 1 to 15
Next 15 structure(s)
Expand all compounds
Collapse all compounds
Show all as text (SweetDB notation)
Show all graphically (SNFG notation)
1. Compound ID: 2066
|
a-Murp2Ac-(1-3)-+
|
-4)-b-D-GlcpNAc-(1-4)-a-D-GalpA-(1-4)-b-L-Rhap-(1-
|
Ser-(1-6)-+ |
Show graphically |
Structure type: polymer chemical repeating unit
Compound class: CPS
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_150900,IEDB_151531,IEDB_225177,IEDB_885823
The structure is contained in the following publication(s):
- Article ID: 671
Gunawardena S, Reddy GP, Wang YH, Kolli VSK, Orlando R, Morris JG, Bush CA "Structure of a muramic acid containing capsular polysaccharide from the pathogenic strain of Vibrio vulnificus ATCC27562" -
Carbohydrate Research 309(1) (1998) 65-76
Vibrio vulnificus strains isolated from septicemia cases and from the environment show a wide variety of capsular types. In an attempt to find common structural features which can be correlated with pathogenicity and toxicity, we have determined structures of the capsular polysaccharides (CPS) from several pathogenic strains. We report the complete structure of the polysaccharide from the pathogenic V. vulnificus strain ATCC27562 using a combination of homonuclear and heteronuclear one-dimensional and two dimensional NMR experiments. The 13C and 1H NMR spectra, including the exchangeable amide proton resonances, have been completely assigned. The amide linkage between Ser and C6 of GalA has been unambiguously determined by water-suppressed 2D NOESY. To verify the structure established by NMR, we have fragmented the polymer employing the Smith degradation procedure. The Smith product identified by NMR and matrix-assisted laser desorption mass spectrometry is consistent with the proposed structure for the CPS, which is composed of D-GlcNAc, MurNAc, D-GalA, L-Rha and is serine-linked as shown: [formula: see text]
structure, mass spectrometry, Vibrio, Capsular polysaccaride, NMR spectrometry
NCBI PubMed ID: 9720237Publication DOI: 10.1016/s0008-6215(98)00115-3Journal NLM ID: 0043535Publisher: Elsevier
Correspondence: bush@umbc.edu
Institutions: Department of Chemistry and Biochemistry, University of Maryland Baltimore County 21250, USA, Complex carbohydrate Research Center and Department of Biochemistry and Molecular Biology, The University of Georgia, 220 Riverbend Road, Athens, GA 30602-4712, USA, Departments of Medicine and Pathology, University of Maryland School of Medicine and Veterans Affairs Medical Center, Baltimore, MD 21201, USA
Methods: NMR-2D, NMR, Smith degradation
- Article ID: 5791
Knirel YA, Van Calsteren M "Bacterial exopolysaccharides" -
Book: Comprehensive Glycoscience: From Chemistry to Systems Biology. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering (2021) 1-75
Bacterial extracellular polysaccharides are known as a cell-bound capsule, a sheath, or a slime, which is excreted into the environment. They play an important role in virulence of medical bacteria and plant-to-symbiont interaction and are used for serotyping of bacteria and production of vaccines. Some exopolysaccharides have commercial applications in industry, and claims of health benefits have been documented for an increasing number of them. Exopolysaccharides have diverse composition and structure, and some contain sugar and non-sugar components that are found in bacterial carbohydrates only. The present article provides an updated collection of the data on exopolysaccharides of various classes of gram-negative and gram-positive bacteria reported until the end of 2019. When known, biosynthesis pathways of exopolysaccharides are treated in a summary manner. References are made to structure and biosynthesis relatedness between exopolysaccharides of different bacterial taxa as well as between bacterial polysaccharides and mammalian glycosaminoglycans.
polysaccharide structure, Gram-negative bacteria, capsule, Biofilm, polysaccharide biosynthesis, gram-positive bacteria, Monosaccharide composition, Bacterial exopolysaccharide, non-sugar component
Publication DOI: 10.1016/B978-0-12-819475-1.00005-5Publisher: Elsevier
Correspondence: marie-rose.vancalsteren@canada.ca; yknirel@gmail.com
Editors: Barchi J, Kamerling H
Institutions: N. D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia, Saint-Hyacinthe Research and Development Centre, Agriculture and Agri-Food Canada, Saint-Hyacinthe, QC, Canada
Expand this compound
Collapse this compound
2. Compound ID: 2150
|
a-Murp2Ac-(1-3)-+
|
b-D-GlcpNAc-(1-4)-a-D-GalpA-(1-2)-Suga
|
Ser-(1-6)-+
Sug = unidentified tetritol = SMILES OC{2}C(C(CO)O)O |
Show graphically |
Structure type: oligomer
Compound class: CPS
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_150900,IEDB_151531
The structure is contained in the following publication(s):
- Article ID: 671
Gunawardena S, Reddy GP, Wang YH, Kolli VSK, Orlando R, Morris JG, Bush CA "Structure of a muramic acid containing capsular polysaccharide from the pathogenic strain of Vibrio vulnificus ATCC27562" -
Carbohydrate Research 309(1) (1998) 65-76
Vibrio vulnificus strains isolated from septicemia cases and from the environment show a wide variety of capsular types. In an attempt to find common structural features which can be correlated with pathogenicity and toxicity, we have determined structures of the capsular polysaccharides (CPS) from several pathogenic strains. We report the complete structure of the polysaccharide from the pathogenic V. vulnificus strain ATCC27562 using a combination of homonuclear and heteronuclear one-dimensional and two dimensional NMR experiments. The 13C and 1H NMR spectra, including the exchangeable amide proton resonances, have been completely assigned. The amide linkage between Ser and C6 of GalA has been unambiguously determined by water-suppressed 2D NOESY. To verify the structure established by NMR, we have fragmented the polymer employing the Smith degradation procedure. The Smith product identified by NMR and matrix-assisted laser desorption mass spectrometry is consistent with the proposed structure for the CPS, which is composed of D-GlcNAc, MurNAc, D-GalA, L-Rha and is serine-linked as shown: [formula: see text]
structure, mass spectrometry, Vibrio, Capsular polysaccaride, NMR spectrometry
NCBI PubMed ID: 9720237Publication DOI: 10.1016/s0008-6215(98)00115-3Journal NLM ID: 0043535Publisher: Elsevier
Correspondence: bush@umbc.edu
Institutions: Department of Chemistry and Biochemistry, University of Maryland Baltimore County 21250, USA, Complex carbohydrate Research Center and Department of Biochemistry and Molecular Biology, The University of Georgia, 220 Riverbend Road, Athens, GA 30602-4712, USA, Departments of Medicine and Pathology, University of Maryland School of Medicine and Veterans Affairs Medical Center, Baltimore, MD 21201, USA
Methods: NMR-2D, NMR, Smith degradation
Expand this compound
Collapse this compound
3. Compound ID: 3080
|
b-D-GlcpNAc-(1-4)-b-Murp2Ac-(1-4)-b-D-GlcpNAc-(1-4)-+ L-Ala-(2-8)-+
| |
D-Ala-(?-?)-PmN2-(?-?)-D-Glu-(2-1)-L-Ala-(2-8)-b-Murp2Ac-(1-4)-b-D-GlcpNAc-(1-4)-b-Murp2Ac-(1-4)-b-D-GlcpNAc-(1-4)-Murp2Ac |
Show graphically |
Structure type: oligomer
Compound class: peptidoglycan
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_241115,IEDB_423183,IEDB_885814
The structure is contained in the following publication(s):
- Article ID: 1112
Popham DL, Helin J, Costello CE, Setlow P "Analysis of the peptidoglycan structure of Bacillus subtilis endospores" -
Journal of Bacteriology 178(22) (1996) 6451-6458
Peptidoglycan was prepared from purified Bacillus subtilis spores of wild-type and several mutant strains. Digestion with muramidase resulted in cleavage of the glycosidic bonds adjacent to muramic acid replaced by peptide or alanine side chains but not the bonds adjacent to muramic lactam. Reduction of the resulting muropeptides allowed their separation by reversed-phase high-pressure liquid chromatography. The structures of 20 muropeptides were determined by amino acid and amino sugar analysis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. In wild-type spores, 50% of the muramic acid had been converted to the lactam and 75% of these lactam residues were spaced regularly at every second muramic acid position in the glycan chains. Single L-alanine side chains were found on 25% of the muramic acid residues. The remaining 25% of the muramic acid had tetrapeptide or tripeptide side chains, and 11% of the diaminopimelic acid in these side chains was involved in peptide cross-links. Analysis of spore peptidoglycan produced by a number of mutants lacking proteins involved in cell wall metabolism revealed structural changes. The most significant changes were in the spores of a dacB mutant which lacks the sporulation-specific penicillin-binding protein 5*. In these spores, only 46% of the muramic acid was in the lactam form, 12% had L-alanine side chains, and 42% had peptide side chains containing diaminopimelic acid, 29% of which was involved in cross-links.
structure, structural, analysis, peptidoglycan, Bacillus, Bacillus subtilis
NCBI PubMed ID: 8932300Journal NLM ID: 2985120RPublisher: American Society for Microbiology
Correspondence: setlow@sun.uchc.edu
Institutions: Department of Biochemistry, University of Connecticut Health Center, Farmington, Connecticut 06030-3305, Mass Spectrometry Resource, Department of Biophysics, Boston University School of Medicine, Boston, Massachusetts 02118-2394
Methods: carboxyl reduction, amino acid analysis, MALDI-TOF MS, HPLC, enzymatic digestion, amino sugar analysis
Expand this compound
Collapse this compound
4. Compound ID: 3102
Structure type: monomer
C9H17N1O7
Trivial name: muramic acid
The structure is contained in the following publication(s):
- Article ID: 1125
Ragousis V, Leondiadis L, Livaniou E, Evangelatos GP "A simple approach to the synthesis of muramic acid and isomuramic acid: 1H and 13C NMR characterisation" -
Carbohydrate Research 297(3) (1997) 289-295
A simple and efficient synthesis of 2-amino-3-O-[(R)-1-carboxyethyl]-2-deoxy-D-glucose (muramic acid, 6) and its stereoisomer 2-amino-3-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose (isomuramic acid, 7) from methyl 2-acetamido-4,6-O-benzylidene-2-deoxy-a-D-glucopyranoside (1) is described. Condensation of the O-3 oxyanion of 1 with an excess of methyl (R,S)-2-bromopropionate, followed by alkaline hydrolysis of the crude product and subsequent acidification, afforded crystalline methyl 2-acetamido-4,6-O-benzylidene-3-O-[(R,S)-1-carboxyethyl]-2-deoxy-a-D-glucopyranoside (2), in 72% yeld, as a mixture of diastereomers. Esterification of 2 with an excess of diazomethane afforded quantitatively the corresponding mixture of epimeric esters, which were very easily separated by column chromatography on silica gel, giving pure (R) and (S) epimeric esters. Removal of the benzylidene and acetyl groups by acid hydrolysis gave, respectively, muramic acid (6), in 95% yield and isomuramic acid (7), in 93% yield. 1H and 13C NMR data are given.
NMR, synthesis, acid, 13C NMR, characterisation, 1H NMR, approach, isomuramic acid, muramic acid, 2-acetamido-2-deoxyglucosides
Publication DOI: 10.1016/S0008-6215(96)00271-6Journal NLM ID: 0043535Publisher: Elsevier
Institutions: Department of Chemistry, Laboratory of Organic Chemistry, University of Athens, Panepistimiopolis, Zographou, 15771 Athens, Greece, Immunochemistry Laboratory, Institute of Radioisotopes and Radiodiagnostic Products, National Centre for Scientific Research ''Demokritos'', Ag. Paraskeui, 153 IOAthens, Greece
Methods: 13C NMR, 1H NMR
Expand this compound
Collapse this compound
5. Compound ID: 3122
|
a-Mur2Ac-(1-3)-+
|
-4)-a-D-GlcpNAc-(1-4)-a-D-GalpA-(1-4)-b-L-Rhap-(1-
|
L-Ser-(2-6)-+ |
Show graphically |
Structure type: polymer chemical repeating unit
Contained glycoepitopes: IEDB_137340,IEDB_141807,IEDB_150900,IEDB_151531,IEDB_225177,IEDB_885823
The structure is contained in the following publication(s):
- Article ID: 1136
Reddy GP, Hayat U, Xu QW, Reddy KV, Wang YH, Chiu KW, Morris JG, Bush CA "Structure determination of the capsular polysaccharide from Vibrio vulnificus strain 6353" -
European Journal of Biochemistry 255(1) (1998) 279-288
Vibrio vulnificus is a pathogenic gram-negative bacterium, endemic to brackish waters, which is often isolated from sediments, from the water column or from shellfish. It is associated with wound infections and septicemia in humans and the virulence of V. vulnificus has been strongly associated with encapsulation. The capsular polysaccharide purified from a virulent strain of V. vulnificus 6353 did not show cross reactivity with antibodies to the capsular polysaccharide of a related pathogenic strain of V. vulnificus (MO6-24) the structure of which was recently reported. NMR spectroscopic analysis of the purified polysaccharide from strain 6353 showed that the polymer is composed of four sugar residues per repeating subunit including 2,6-dideoxy-2-N-acetylamino-α-D-glucose (QuiNAc), 2-deoxy-2-N-acetylamino-α-D-galactose (α-D-GalNAc), 2-deoxy-2-N-acetylamino-α-D-galcturonic acid (α-D-GalNAcA) and 2-N-acetylamino-α-D-glucuronamide (α-D-GlcNAcANH2). The 1H- and 13C NMR spectra were completely assigned by homonuclear and heteronuclear NMR spectroscopy. Sugar types and anomeric configurations were determined from proton homonuclear coupling constants and glycosidic linkages were determined from 1H-13C heteronuclear multiple bond correlation spectra. Sugar identities were confirmed by high performance anion-exchange chromatography and absolute configurations were determined by gas chromatography in combination with molecular modeling and NMR spectroscopy. The structure of the polysaccharide repeating unit is: [→4)-α-D-GalpNAc-(1→3)-α-D-GalpNAcA-(1→3)-α-D-QuipNAc-(1→]n α-D-GlcpNAcANH2(1→4)-→. While there are some common features shared among the structures of the capsular polysaccharides of pathogenic strains of V. vulnificus, there are distinct differences in the detailed structures.
NMR, structure, polysaccharide, bacteria, Vibrio, Vibrio vulnificus
NCBI PubMed ID: 9692929Publication DOI: 10.1046/j.1432-1327.1998.2550279.xJournal NLM ID: 0107600Publisher: Oxford, UK: Blackwell Science Ltd. on behalf of the Federation of European Biochemical Societies
Correspondence: bush@umbc.edu
Institutions: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore MD, USA, Departments of Medicine and Pathology, University of Maryland School of Medicine and Veterans Affairs Medical Center, Baltimore MD, USA
Methods: 13C NMR, 1H NMR, NMR-2D, HPLC
Expand this compound
Collapse this compound
6. Compound ID: 3123
|
a-Mur2Ac-(1-3)-+
|
-4)-b-D-GlcpNAc-(1-4)-a-D-GalpA-(1-4)-b-L-Rhap-(1-
|
L-Ser-(2-6)-+ |
Show graphically |
Structure type: polymer chemical repeating unit
Compound class: CPS
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_150900,IEDB_151531,IEDB_225177,IEDB_885823
The structure is contained in the following publication(s):
- Article ID: 1136
Reddy GP, Hayat U, Xu QW, Reddy KV, Wang YH, Chiu KW, Morris JG, Bush CA "Structure determination of the capsular polysaccharide from Vibrio vulnificus strain 6353" -
European Journal of Biochemistry 255(1) (1998) 279-288
Vibrio vulnificus is a pathogenic gram-negative bacterium, endemic to brackish waters, which is often isolated from sediments, from the water column or from shellfish. It is associated with wound infections and septicemia in humans and the virulence of V. vulnificus has been strongly associated with encapsulation. The capsular polysaccharide purified from a virulent strain of V. vulnificus 6353 did not show cross reactivity with antibodies to the capsular polysaccharide of a related pathogenic strain of V. vulnificus (MO6-24) the structure of which was recently reported. NMR spectroscopic analysis of the purified polysaccharide from strain 6353 showed that the polymer is composed of four sugar residues per repeating subunit including 2,6-dideoxy-2-N-acetylamino-α-D-glucose (QuiNAc), 2-deoxy-2-N-acetylamino-α-D-galactose (α-D-GalNAc), 2-deoxy-2-N-acetylamino-α-D-galcturonic acid (α-D-GalNAcA) and 2-N-acetylamino-α-D-glucuronamide (α-D-GlcNAcANH2). The 1H- and 13C NMR spectra were completely assigned by homonuclear and heteronuclear NMR spectroscopy. Sugar types and anomeric configurations were determined from proton homonuclear coupling constants and glycosidic linkages were determined from 1H-13C heteronuclear multiple bond correlation spectra. Sugar identities were confirmed by high performance anion-exchange chromatography and absolute configurations were determined by gas chromatography in combination with molecular modeling and NMR spectroscopy. The structure of the polysaccharide repeating unit is: [→4)-α-D-GalpNAc-(1→3)-α-D-GalpNAcA-(1→3)-α-D-QuipNAc-(1→]n α-D-GlcpNAcANH2(1→4)-→. While there are some common features shared among the structures of the capsular polysaccharides of pathogenic strains of V. vulnificus, there are distinct differences in the detailed structures.
NMR, structure, polysaccharide, bacteria, Vibrio, Vibrio vulnificus
NCBI PubMed ID: 9692929Publication DOI: 10.1046/j.1432-1327.1998.2550279.xJournal NLM ID: 0107600Publisher: Oxford, UK: Blackwell Science Ltd. on behalf of the Federation of European Biochemical Societies
Correspondence: bush@umbc.edu
Institutions: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore MD, USA, Departments of Medicine and Pathology, University of Maryland School of Medicine and Veterans Affairs Medical Center, Baltimore MD, USA
Methods: 13C NMR, 1H NMR, NMR-2D, HPLC
Expand this compound
Collapse this compound
7. Compound ID: 3649
Structure type: polymer chemical repeating unit
Compound class: O-polysaccharide, O-antigen
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_885814
The structure is contained in the following publication(s):
- Article ID: 1367
Bateman KP, Banoub JH, Thibault P "Probing the microheterogeneity of O-specific chains from Yersinia ruckeri using capillary zone electrophoresis/electrospray mass spectrometry" -
Electrophoresis 17(12) (1996) 1818-1828
Lipopolysaccharide, LPS, chain, O-specific, spectrometry, mass spectrometry, Yersinia, Capillary zone electrophoresis, electrospray mass spectrometry, microheterogeneity, Yersinia ruckeri
Journal NLM ID: 8204476Publisher: Wiley-VCH
Correspondence: pierre.thibault@nec.ca
Institutions: Institute for Marine Biosciences, Nova Scotia, Canada
Methods: CE-ESI-MS
Expand this compound
Collapse this compound
8. Compound ID: 4313
|
b-D-GlcpNAc-(1-4)-+
|
D-Ala-(2-1)-D-Ala-(2-1)-mPmN2-(2-5)-D-Glu-(2-1)-L-Ala-(2-8)-a-Murp2Ac-(1---P---P----/undecaprenol-Z8E3/ |
Show graphically |
Structure type: oligomer
Aglycon: undecaprenol-Z8E3
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_885814
The structure is contained in the following publication(s):
- Article ID: 1616
Guan Z, Breazeale SD, Raetz CR "Extraction and identification by mass spectrometry of undecaprenyl diphosphate-MurNAc-pentapeptide-GlcNAc from Escherichia coli" -
Analytical Biochemistry 345(2) (2005) 336-339
Undecaprenyl diphosphate-MurNAc-pentapeptide-GlcNAc (lipid II) is extracted from Escherichia coli cells by utilizing its unusual pH-dependent solubility property in a Bligh-Dyer system, and identified by electrospray ionization mass spectrometry in conjunction with a novel 15N mass shift analysis. The described approach will facilitate the structural characterization of lipid II variants from diverse bacteria, including antibiotic-resistant mutants, as well as the numerous minor uncharacterized lipids present in all biological systems
Escherichia coli, mass spectrometry, Lipid II, 15N mass shift analysis
NCBI PubMed ID: 16118008Publication DOI: 10.1016/j.ab.2005.07.002Journal NLM ID: 0370535Publisher: Academic Press
Correspondence: zguan@biochem.duke.edu
Institutions: Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA
Methods: ESI-MS
Expand this compound
Collapse this compound
9. Compound ID: 4329
|
a-Murp2Ac-(1-3)-+
|
b-D-GlcpNAc-(1-2)-a-L-Rhap-(1-3)-a-D-Fucp-(1-2)-{{{-a-L-Rhap-(1-3)-a-D-Fucp-(1-2)-}}}/n=19/-a-L-Rhap-(1-3)-a-D-Fucp |
Show graphically |
Structure type: oligomer
Trivial name: S-layer glycan
Contained glycoepitopes: IEDB_115015,IEDB_135813,IEDB_136105,IEDB_137340,IEDB_141807,IEDB_142489,IEDB_143253,IEDB_149135,IEDB_151531,IEDB_225177,IEDB_885823,SB_86
The structure is contained in the following publication(s):
- Article ID: 1623
Kahlig H, Kolarich D, Zayni S, Scheberl A, Kosma P, Schäffer C, Messner P "N-Acetylmuramic acid as capping element of a-D-fucose-containing S-layer glycoprotein glycans from Geobacillus tepidamans GS5-97T" -
Journal of Biological Chemistry 280(21) (2005) 20292-20299
Geobacillus tepidamans GS5-97(T) is a novel Gram-positive, moderately thermophilic bacterial species that is covered by a glycosylated surface layer (S-layer) protein. The isolated and purified S-layer glycoprotein SgtA was ultrastructurally and chemically investigated and showed several novel properties. By SDS-PAGE, SgtA was separated into four distinct bands in an apparent molecular mass range of 106-166 kDa. The three high molecular mass bands gave a positive periodic acid-Schiff staining reaction, whereas the 106-kDa band was nonglycosylated. Glycosylation of SgtA was investigated by means of chemical analyses, 600-MHz nuclear magnetic resonance spectroscopy, and electrospray ionization quadrupole time-of-fight mass spectrometry. Glycopeptides obtained after Pronase digestion revealed the glycan structure [→2)-α-L-Rhap-(1→3)-α-D-Fucp-(1→](n=approximately 20), with D-fucopyranose having never been identified before as a constituent of S-layer glycans. The rhamnose residue at the nonreducing end of the terminal repeating unit of the glycan chain was di-substituted. For the first time, (R)-N-acetylmuramic acid, the key component of prokaryotic peptidoglycan, was found in an α-linkage to carbon 3 of the terminal rhamnose residue, serving as capping motif of an S-layer glycan. In addition, that rhamnose was substituted at position 2 with a β-N-acetylglucosamine residue. The S-layer glycan chains were bound via the trisaccharide core →2)-α-L-Rhap-(1→3)-α-L-Rhap-(1→3)-α-L-Rhap-(1→ to carbon 3 of β-D-galactose, which was attached in O-glycosidic linkage to serine and threonine residues of SgtA of G. tepidamans GS5-97(T).
structure, mass spectrometry, glycosylation, Gram-positive, glycoprotein, D-fucose, Geobacillus, SgtA, S-layer glycan
NCBI PubMed ID: 15781455Publication DOI: 10.1074/jbc.M501724200Journal NLM ID: 2985121RPublisher: Baltimore, MD: American Society for Biochemistry and Molecular Biology
Institutions: Department of Organic Chemistry, University of Vienna, Austria
Methods: NMR, sugar analysis, amino acid analysis, MS
Expand this compound
Collapse this compound
10. Compound ID: 4480
|
b-D-GlcpNAc-(1-4)-+
|
Ala-(2-1)-PmN2-(2-5)-Glu-(2-1)-Ala-(2-8)-Mur2Ac |
Show graphically |
Structure type: oligomer
Compound class: peptidoglycan
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_885814
The structure is contained in the following publication(s):
Expand this compound
Collapse this compound
11. Compound ID: 4610
Structure type: polymer chemical repeating unit
Compound class: O-polysaccharide, O-antigen
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_885814
The structure is contained in the following publication(s):
- Article ID: 1778
Knirel YA, Kochetkov NK "The structure of lipopolysaccharides of gram-negative bacteria. III. The structure of O-antigens: A review" -
Biochemistry (Moscow) 59(12) (1994) 1325-1383
This review summarizes data on the composition and structure of the O-antigens, the polysaccharide chains of the outer-membrane lipopolysaccharides (LPS) of Gram-negative bacteria defining the immunospecificity of these microbial cells. Special reference is given to some structural features of the O-antigens, such as the presence of unique monosaccharides and noncarbohydrate components, masked regularity, and the occurrence in one microorganism of LPS with structurally different polysaccharide chains. Antigenic relationships between microorganisms belonging to different taxonomic groups are discussed.
structure, O-antigen, chemical composition, bacterial lipopolysaccharides, Salmonella livingstone C1
NCBI PubMed ID: 7533007Journal NLM ID: 0376536Publisher: Nauka/Interperiodica
Institutions: Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russia
- Article ID: 1798
Banoub JH, Shaw DH, Pang H, Krepinsky JJ, Nakhla NA, Patel T "Structural elucidation of the O-specific antigen of Yersinia ruckeri by fast atom bombardment mass spectrometry (FAB-MS)" -
Biomedical and Environmental Mass Spectrometry 19 (1990) 787-790
NCBI PubMed ID: 2088577Journal NLM ID: 8603224Publisher: Wiley
Institutions: Northwest Atlantic Fisheries Centre, St. John's, Newfoundland, Canada
Methods: FAB-MS
Expand this compound
Collapse this compound
12. Compound ID: 5785
|
b-D-GlcpNAc-(1-4)-+
|
mPmN2-(2-5)-D-Glu-(2-1)-L-Ala-(2-8)-Mur2Ac6Ac |
Show graphically |
Structure type: oligomer
; 910.36
Trivial name: muramyl peptide
Compound class: peptidoglycan
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_885814
The structure is contained in the following publication(s):
- Article ID: 2538
Johannsen L, Rosenthal RS, MArtin SA, Cady AB, Obal F (Jr), Guinand M, Krueger JM "Somnogenic activity of O-acetylated and dimeric muramyl peptides" -
Infection and Immunity 57 (1989) 2726-2732
Slow-wave sleep-promoting factors in brain and urine were identified as muramyl peptides (MPs), the building blocks of bacterial cell wall peptidoglycan. In this study, structural variations of MPs that occur naturally in bacterial peptidoglycan were investigated for somnogenic activity. Monomeric and dimeric MPs were isolated and purified from Neisseria gonorrhoeae and Actinomadura sp. strain R39. The structures of these MPs were verified by fast atom bombardment mass spectroscopy and tandem mass spectroscopy. After intracerebroventricular administration of MPs, electroencephalograms and brain temperatures of rabbits were recorded for 6 h and were analyzed to determine durations of slow-wave sleep, rapid-eye-movement sleep, and wakefulness. The 6-O acetylation of muramic acid enhanced the somnogenic effects of certain monomeric MPs relative to their non-O-acetylated (but otherwise identical) counterparts. Two monomeric MPs containing an unsubstituted amide (i.e., Iso-Gln) were inactive, thus confirming previous results showing that amidation of a variety of MPs can block somnogenic activity. Two peptide-cross-linked MP dimers tested had no effect on slow-wave sleep, although a third peptide-cross-linked MP containing a 1,6-anhydro muramyl end on one of its monomeric subunits, a structure that enhances somnogenic potency of un-cross-linked monomers, was somnogenic. Two dimers connected by glycosidic bonds and containing an Iso-Gln moiety were inactive. Two other glycosidically linked dimers that also contained an Iso-Gln moiety, but were of lower molecular weight, were somnogenic. In summary, 6-O acetylation of muramic acid in somnogenic MPs enhances activity, and as a class, peptide-linked dimeric MPs tend to be less active than their constituent monomers.
NCBI PubMed ID: 2759708Journal NLM ID: 0246127Publisher: American Society for Microbiology
Institutions: Department of Physiology and Biophysics, University of Tennessee, Memphis 38163
Methods: FAB-MS, MS/MS, biological assays, HPLC
Expand this compound
Collapse this compound
13. Compound ID: 5786
|
b-D-GlcpNAc-(1-4)-+
|
mPmN2-(2-5)-D-Glu-(2-1)-L-Ala-(2-8)-Mur2Ac |
Show graphically |
Structure type: oligomer
; 868.35
Trivial name: muramyl peptide
Compound class: peptidoglycan
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_885814
The structure is contained in the following publication(s):
- Article ID: 2538
Johannsen L, Rosenthal RS, MArtin SA, Cady AB, Obal F (Jr), Guinand M, Krueger JM "Somnogenic activity of O-acetylated and dimeric muramyl peptides" -
Infection and Immunity 57 (1989) 2726-2732
Slow-wave sleep-promoting factors in brain and urine were identified as muramyl peptides (MPs), the building blocks of bacterial cell wall peptidoglycan. In this study, structural variations of MPs that occur naturally in bacterial peptidoglycan were investigated for somnogenic activity. Monomeric and dimeric MPs were isolated and purified from Neisseria gonorrhoeae and Actinomadura sp. strain R39. The structures of these MPs were verified by fast atom bombardment mass spectroscopy and tandem mass spectroscopy. After intracerebroventricular administration of MPs, electroencephalograms and brain temperatures of rabbits were recorded for 6 h and were analyzed to determine durations of slow-wave sleep, rapid-eye-movement sleep, and wakefulness. The 6-O acetylation of muramic acid enhanced the somnogenic effects of certain monomeric MPs relative to their non-O-acetylated (but otherwise identical) counterparts. Two monomeric MPs containing an unsubstituted amide (i.e., Iso-Gln) were inactive, thus confirming previous results showing that amidation of a variety of MPs can block somnogenic activity. Two peptide-cross-linked MP dimers tested had no effect on slow-wave sleep, although a third peptide-cross-linked MP containing a 1,6-anhydro muramyl end on one of its monomeric subunits, a structure that enhances somnogenic potency of un-cross-linked monomers, was somnogenic. Two dimers connected by glycosidic bonds and containing an Iso-Gln moiety were inactive. Two other glycosidically linked dimers that also contained an Iso-Gln moiety, but were of lower molecular weight, were somnogenic. In summary, 6-O acetylation of muramic acid in somnogenic MPs enhances activity, and as a class, peptide-linked dimeric MPs tend to be less active than their constituent monomers.
NCBI PubMed ID: 2759708Journal NLM ID: 0246127Publisher: American Society for Microbiology
Institutions: Department of Physiology and Biophysics, University of Tennessee, Memphis 38163
Methods: FAB-MS, MS/MS, biological assays, HPLC
Expand this compound
Collapse this compound
14. Compound ID: 5787
|
b-D-GlcpNAc-(1-4)-Mur-(8-2)-L-Ala-(1-2)-D-Glu-(5-2)-+
|
b-D-GlcpNAc-(1-4)-Mur-(8-2)-L-Ala-(1-2)-D-Glu-(5-2)-mPmN2-(1-2)-D-Ala-(1-6)-mPmN2-(1-2)-D-Ala |
Show graphically |
Structure type: oligomer
; 1860.77
Trivial name: muramyl peptide
Compound class: peptidoglycan
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_885814
The structure is contained in the following publication(s):
- Article ID: 2538
Johannsen L, Rosenthal RS, MArtin SA, Cady AB, Obal F (Jr), Guinand M, Krueger JM "Somnogenic activity of O-acetylated and dimeric muramyl peptides" -
Infection and Immunity 57 (1989) 2726-2732
Slow-wave sleep-promoting factors in brain and urine were identified as muramyl peptides (MPs), the building blocks of bacterial cell wall peptidoglycan. In this study, structural variations of MPs that occur naturally in bacterial peptidoglycan were investigated for somnogenic activity. Monomeric and dimeric MPs were isolated and purified from Neisseria gonorrhoeae and Actinomadura sp. strain R39. The structures of these MPs were verified by fast atom bombardment mass spectroscopy and tandem mass spectroscopy. After intracerebroventricular administration of MPs, electroencephalograms and brain temperatures of rabbits were recorded for 6 h and were analyzed to determine durations of slow-wave sleep, rapid-eye-movement sleep, and wakefulness. The 6-O acetylation of muramic acid enhanced the somnogenic effects of certain monomeric MPs relative to their non-O-acetylated (but otherwise identical) counterparts. Two monomeric MPs containing an unsubstituted amide (i.e., Iso-Gln) were inactive, thus confirming previous results showing that amidation of a variety of MPs can block somnogenic activity. Two peptide-cross-linked MP dimers tested had no effect on slow-wave sleep, although a third peptide-cross-linked MP containing a 1,6-anhydro muramyl end on one of its monomeric subunits, a structure that enhances somnogenic potency of un-cross-linked monomers, was somnogenic. Two dimers connected by glycosidic bonds and containing an Iso-Gln moiety were inactive. Two other glycosidically linked dimers that also contained an Iso-Gln moiety, but were of lower molecular weight, were somnogenic. In summary, 6-O acetylation of muramic acid in somnogenic MPs enhances activity, and as a class, peptide-linked dimeric MPs tend to be less active than their constituent monomers.
NCBI PubMed ID: 2759708Journal NLM ID: 0246127Publisher: American Society for Microbiology
Institutions: Department of Physiology and Biophysics, University of Tennessee, Memphis 38163
Methods: FAB-MS, MS/MS, biological assays, HPLC
Expand this compound
Collapse this compound
15. Compound ID: 5868
Structure type: oligomer
Trivial name: muramyl peptide
Compound class: peptidoglycan
Contained glycoepitopes: IEDB_135813,IEDB_137340,IEDB_141807,IEDB_151531,IEDB_1635957,IEDB_241115,IEDB_423183,IEDB_885814
The structure is contained in the following publication(s):
- Article ID: 2594
Kohlrausch U, Holtje JV "Analysis of murein and murein precursors during antibiotic-induced lysis of Escherichia coli" -
Journal of Bacteriology 173 (1991) 3425-3431
Lysis of Escherichia coli induced by either D-cycloserine, moenomycin, or penicillin G was monitored by studying murein metabolism. The levels of the soluble murein precursor UDP-N-acetylmuramyl-L-alanyl-D-glutamyl-m-diaminopimelyl-D-alanyl- D-alanine (UDP-MurNAc-pentapeptide) and the carrier-linked MurNAc-(pentapeptide)-pyrophosphoryl-undecaprenol as well as N-acetylglucosamine-β-1,4-MurNAc-(pentapeptide)-pyrophosphoryl- undecaprenol varied in a specific way. In the presence of penicillin, which is known to interfere with the cross-linking of murein, the concentration of the lipid-linked precursors unexpectedly decreased before the onset of lysis, although the level of UDP-MurNAc-pentapeptide remained normal. In the case of moenomycin, which specifically blocks the formation of the murein polysaccharide strands, the lipid-linked precursors as well as UDP-MurNAc-pentapeptide accumulated as was expected. D-Cycloserine, which inhibits the biosynthesis of UDP-MurNAc-pentapeptide, consequently caused a decrease in all three precursors. The muropeptide composition of the murein showed general changes such as an increase in the unusual DL-cross bridge between two neighboring meso-diaminopimelic acid residues and, as a result of uncontrolled DL- and DD-carboxypeptidase activity, an increase in tripeptidyl and a decrease in tetrapeptidyl and pentapeptidyl moieties. The average length of the glycan strands decreased. When the glycan strands were fractionated according to length, a dramatic increase in the amount of single disaccharide units was observed not only in the presence of penicillin but also in the presence of moenomycin. This result is explained by the action of an exo-muramidase, such as the lytic transglycosylases present in E. coli. It is proposed that antibiotic-induced bacteriolysis is the result of a zipperlike splitting of the murein net by exo-muramidases locally restricted to the equatorial zone of the cell.
NCBI PubMed ID: 2045364Journal NLM ID: 2985120RPublisher: American Society for Microbiology
Institutions: Abteilung Biochemie, Max-Planck-Institut für Entwicklungsbiologie, Munich, Germany
Expand this compound
Collapse this compound
Next 15 structure(s)
Total list of structure IDs on all result pages of the current query:
Total list of corresponding CSDB IDs (permanent record IDs):
Execution: 1 sec